Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-082558
Filing Date
2023-07-20
Accepted
2023-07-20 08:00:28
Documents
1
Group Members
ADAR1 CAPITAL MANAGEMENT GP, LLCADAR1 CAPITAL MANAGEMENT, LLCDANIEL SCHNEEBERGER

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2321461d1_sc13g.htm SC 13G 104702
  Complete submission text file 0001104659-23-082558.txt   106319
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Subject) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90445 | Film No.: 231098111
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738
Business Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738 512-531-9088
ADAR1 Partners, LP (Filed by) CIK: 0001758866 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G